Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54(3):271–6.

Article  CAS  Google Scholar 

Barron KS. Kawasaki disease in children. Curr Opin Rheumatol. 1998;10(1):29–37.

Article  MathSciNet  CAS  Google Scholar 

McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: A Scientific Statement for Health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e99.

Article  Google Scholar 

Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, Yanagawa H. Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int. 2008;50(3):287–90.

Article  Google Scholar 

Wu MH, Lin MT, Chen HC, Kao FY, Huang SK. Postnatal risk of acquiring Kawasaki Disease: a Nationwide Birth Cohort Database Study. J Pediatr. 2017;180:80–6. e2.

Article  Google Scholar 

Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation. 2000;101(25):2935–41.

Article  CAS  Google Scholar 

Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379–85.

Article  CAS  Google Scholar 

Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr. 1992;121(5 Pt 1):684–8.

Article  CAS  Google Scholar 

Yuan S, Zhang S, Zhuang Y, Zhang H, Bai J, Hou Q. Interleukin-17 stimulates STAT3-Mediated endothelial cell activation for Neutrophil Recruitment. Cell Physiol Biochem. 2015;36(6):2340–56.

Article  CAS  Google Scholar 

Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P, et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum. 2010;62(4):929–39.

Article  CAS  Google Scholar 

Karbach S, Croxford AL, Oelze M, Schuler R, Minwegen D, Wegner J, et al. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol. 2014;34(12):2658–68.

Article  CAS  Google Scholar 

Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23(1):38–54.

Article  CAS  Google Scholar 

Sohn MH, Noh SY, Chang W, Shin KM, Kim DS. Circulating interleukin 17 is increased in the acute stage of Kawasaki disease. Scand J Rheumatol. 2003;32(6):364–6.

Article  CAS  Google Scholar 

Jia S, Li C, Wang G, Yang J, Zu Y. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol. 2010;162(1):131–7.

Article  CAS  Google Scholar 

Nordlohne J, Helmke A, Ge S, Rong S, Chen R, Waisman A, et al. Aggravated atherosclerosis and vascular inflammation with reduced kidney function depend on Interleukin-17 receptor A and are normalized by inhibition of Interleukin-17A. JACC Basic Transl Sci. 2018;3(1):54–66.

Article  Google Scholar 

Sakurai Y. Autoimmune aspects of Kawasaki Disease. J Investig Allergol Clin Immunol. 2018:0.

Lin IC, Kuo HC, Lin YJ, Wang FS, Wang L, Huang SC, et al. Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis. PLoS ONE. 2012;7(6):e38635.

Article  CAS  Google Scholar 

Lin IC, Suen JL, Huang SK, Huang SC, Huang HC, Kuo HC, et al. Dectin-1/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease. Immunobiology. 2013;218(2):201–12.

Article  CAS  Google Scholar 

Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA, Taylor PR, et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and toll-like receptors. Eur J Immunol. 2008;38(2):500–6.

Article  CAS  Google Scholar 

LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8(6):630–8.

Article  CAS  Google Scholar 

Wu NL, Huang DY, Tsou HN, Lin YC, Lin WW. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6. J Invest Dermatol. 2015;135(2):490–8.

Article  CAS  Google Scholar 

Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129(3):311–21.

Article  CAS  Google Scholar 

Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y, et al. JCS/JSCS 2020 Guideline on diagnosis and management of Cardiovascular Sequelae in Kawasaki Disease. Circulation Journal: Official J Japanese Circulation Soc. 2020;84(8):1348–407.

Article  CAS  Google Scholar 

Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Rheumatol. 2022;74(4):586–96.

Article  Google Scholar 

Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K, et al. A new Z score curve of the coronary arterial internal diameter using the Lambda-Mu-Sigma Method in a Pediatric Population. J Am Soc Echocardiography: Official Publication Am Soc Echocardiography. 2016;29(8):794–801e29.

Article  Google Scholar 

Lin MT, Chang CH, Hsieh WC, Chang CE, Chang YM, Chen YC, et al. Coronary diameters in Taiwanese children younger than 6 Years Old: Z-Score regression equations derived from body surface area. Acta Cardiol Sin. 2014;30(4):266–73.

Google Scholar 

Hsu AY, Peng Z, Luo H, Loison F. Isolation of human neutrophils from whole blood and Buffy Coats. J Vis Exp. 2021(175).

Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–20.

Article  CAS  Google Scholar 

Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–9.

Article  CAS  Google Scholar 

Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.

Article  CAS  Google Scholar 

Leng N, Dawson JA, Thomson JA, Ruotti V, Rissman AI, Smits BM, et al. EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics. 2013;29(8):1035–43.

Article  CAS  Google Scholar 

Ko TM, Kuo HC, Chang JS, Chen SP, Liu YM, Chen HW, et al. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease. Circul Res. 2015;116(5):876–83.

Article  CAS  Google Scholar 

Wu L, Chen Y, Zhong S, Li Y, Dai X, Di Y. Blood N-terminal pro-brain natriuretic peptide and Interleukin-17 for distinguishing incomplete Kawasaki Disease from Infectious diseases. Indian Pediatr. 2015;52(6):477–80.

Article  Google Scholar 

Guo MM, Tseng WN, Ko CH, Pan HM, Hsieh KS, Kuo HC. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy. 2015;70(3):310–8.

Article  CAS  Google Scholar 

McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in Health and Disease. Immunity. 2019;50(4):892–906.

Article  CAS  Google Scholar 

Mai J, Nanayakkara G, Lopez-Pastrana J, Li X, Li YF, Wang X, et al. Interleukin-17A promotes aortic endothelial cell activation via Transcriptionally and post-translationally activating p38 mitogen-activated protein kinase (MAPK) pathway. J Biol Chem. 2016;291(10):4939–54.

Article  CAS  Google Scholar 

Ghannam S, Dejou C, Pedretti N, Giot JP, Dorgham K, Boukhaddaoui H, et al. CCL20 and beta-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions. J Immunol. 2011;186(3):1411–20.

Article  CAS  Google Scholar 

Takahashi K, Oharaseki T, Yokouchi Y. Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int J Rheum Dis. 2018;21(1):31–5.

Article  CAS  Google Scholar 

Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47(3):305–10.

Article  Google Scholar 

Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184(7):940–3.

Article  CAS  Google Scholar 

Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health. 2021;5(12):852–61.

Article  CAS  Google Scholar 

Portman MA, Dahdah NS, Slee A, Olson AK, Choueiter NF, Soriano BD et al. Etanercept with IVIg for Acute Kawasaki Disease: a Randomized Controlled Trial. Pediatrics. 2019;143(6).

Shinjo T, Iwashita M, Yamashita A, Sano T, Tsuruta M, Matsunaga H, et al. IL-17A synergistically enhances TNFalpha-induced IL-6 and CCL20 production in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2016;477(2):241–6.

Article  CAS  Google Scholar 

Chang SF, Liu SF, Chen CN, Kuo HC. Serum IP-10 and IL-17 from Kawasaki disease patients induce calcification-related genes and proteins in human coronary artery smooth muscle cells in vitro. Cell Biosci. 2020;10:36.

Article  Google Scholar 

Liu G, Guo J, Liu J, Wang Z, Liang D. Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells. Clin Immunol. 2014;154(2):127–40.

Article  CAS  Google Scholar